US equities
|
ANT
$95.44
▲+14.99%
NVDA
$148.23
▼-1.81%
AMD
$480.26
▼-9.41%
MU
$698.09
▼-1.02%
SPCX
$137.65
▼-4.08%
SNDK
$767.87
▼-1.08%
AMZN
$258.75
▼-3.36%
MSFT
$502.32
▼-1.17%
ANT
$95.44
▲+14.99%
NVDA
$148.23
▼-1.81%
AMD
$480.26
▼-9.41%
MU
$698.09
▼-1.02%
SPCX
$137.65
▼-4.08%
SNDK
$767.87
▼-1.08%
AMZN
$258.75
▼-3.36%
MSFT
$502.32
▼-1.17%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about J/R/ Rahn
Recent news which mentions J/R/ Rahn
From Pharma To Psychedelics, Robert Barrow, CEO Of MindMed: Meet Our Speakers
April 04, 2022
Tickers
MNMD
Tags
Penny Stocks
Benzinga
MindMed
From
Benzinga
EXCLUSIVE: MindMed CEO Rob Barrow On Growth Aspirations, Development Pipeline
December 10, 2021
Tickers
MNMD
NDAQ
Tags
MNMD
Small Cap
Interview
From
Benzinga
EXCLUSIVE: Kevin O'Leary Unpacks Deal Flow, Investments, Perspectives On Disruptive Innovation
August 31, 2021
Tickers
IPOS
MNMD
Tags
Media
Interview
Josh Richards
From
Benzinga